Skip to content
Homepage
Author:
Zymeworks Inc.
Posted Date:
July 16, 2026
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
Zymeworks Inc.
July 16, 2026
Zymeworks to Acquire Theravance Biopharma, Inc.
Zymeworks Inc.
June 29, 2026
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Zymeworks Inc.
June 15, 2026
